Aarti Pharmalabs Limited (AARTIPHARM) - Total Liabilities

Latest as of June 2025: Rs-19.90 Billion INR ≈ $-215.20 Million USD

Based on the latest financial reports, Aarti Pharmalabs Limited (AARTIPHARM) has total liabilities worth Rs-19.90 Billion INR (≈ $-215.20 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Aarti Pharmalabs Limited to assess how effectively this company generates cash.

Aarti Pharmalabs Limited - Total Liabilities Trend (2020–2025)

This chart illustrates how Aarti Pharmalabs Limited's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Aarti Pharmalabs Limited to evaluate the company's liquid asset resilience ratio.

Aarti Pharmalabs Limited Competitors by Total Liabilities

The table below lists competitors of Aarti Pharmalabs Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Yunnan Tourism Co Ltd SHE:002059	China	CN¥1.87 Billion
Vitesse Energy Inc NYSE:VTS	USA	$282.67 Million
Astra Otoparts Tbk JK:AUTO	Indonesia	Rp6.18 Trillion
BAE Systems plc LSE:BA	UK	GBX25.74 Billion
Viglacera Corp JSC VN:VGC	Vietnam	₫14.87 Trillion
Shenzhen Easttop Supply Chain Management Co Ltd SHE:002889	China	CN¥2.59 Billion
Lotte Confectionery Co Ltd KO:280360	Korea	₩2.27 Trillion
Orrstown Financial Services Inc NASDAQ:ORRF	USA	$4.95 Billion

Liability Composition Analysis (2020–2025)

This chart breaks down Aarti Pharmalabs Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AARTIPHARM market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	N/A	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.00	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	N/A	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aarti Pharmalabs Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aarti Pharmalabs Limited (2020–2025)

The table below shows the annual total liabilities of Aarti Pharmalabs Limited from 2020 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs9.16 Billion ≈ $99.12 Million	+11.08%
2024-03-31	Rs8.25 Billion ≈ $89.23 Million	+20.35%
2023-03-31	Rs6.86 Billion ≈ $74.14 Million	+4.91%
2022-03-31	Rs6.53 Billion ≈ $70.67 Million	+2807768.13%
2021-03-31	Rs232.71K ≈ $2.52K	+24.61%
2020-03-31	Rs186.75K ≈ $2.02K	--

About Aarti Pharmalabs Limited

NSE:AARTIPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$725.68 Million

Rs67.10 Billion INR

Market Cap Rank

#10661 Global

#510 in India

Share Price

Rs740.25

Change (1 day)

+4.39%

52-Week Range

Rs591.95 - Rs964.90

All Time High

Rs964.90